Corvus Pharmaceuticals, Inc. (CRVS)
13.93
-0.46
(-3.20%)
USD |
NASDAQ |
Sep 08, 16:00
13.93
0.00 (0.00%)
Pre-Market: 08:06
Corvus Pharmaceuticals Price : 13.93 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 14.01 | 14.32 | 13.85 | 13.93 | 1.033M |
| Sep 04, 2026 | 14.34 | 14.74 | 14.34 | 14.39 | 626950.0 |
| Sep 03, 2026 | 14.38 | 14.72 | 13.98 | 14.65 | 938430.0 |
| Sep 02, 2026 | 14.38 | 14.82 | 13.87 | 14.20 | 619857.0 |
| Sep 01, 2026 | 13.86 | 14.30 | 13.84 | 14.27 | 460169.0 |
| Aug 31, 2026 | 14.09 | 14.16 | 13.71 | 14.04 | 883147.0 |
| Aug 28, 2026 | 14.60 | 14.60 | 13.98 | 14.16 | 644535.0 |
| Aug 27, 2026 | 14.74 | 15.14 | 14.62 | 14.72 | 508075.0 |
| Aug 26, 2026 | 14.55 | 15.04 | 14.34 | 14.73 | 692829.0 |
| Aug 25, 2026 | 14.30 | 14.83 | 14.30 | 14.56 | 642256.0 |
| Aug 24, 2026 | 14.37 | 14.37 | 13.78 | 14.09 | 513477.0 |
| Aug 21, 2026 | 14.52 | 14.76 | 14.38 | 14.46 | 473786.0 |
| Aug 20, 2026 | 15.15 | 15.31 | 14.14 | 14.33 | 783580.0 |
| Aug 19, 2026 | 15.20 | 15.72 | 14.94 | 15.40 | 846328.0 |
| Aug 18, 2026 | 14.75 | 15.14 | 14.61 | 14.83 | 635372.0 |
| Aug 17, 2026 | 14.82 | 15.23 | 14.68 | 14.91 | 505991.0 |
| Aug 14, 2026 | 14.98 | 15.18 | 14.61 | 14.89 | 777881.0 |
| Aug 13, 2026 | 15.25 | 15.44 | 14.91 | 15.14 | 1.007M |
| Aug 12, 2026 | 14.80 | 15.29 | 14.74 | 15.05 | 1.025M |
| Aug 11, 2026 | 13.92 | 14.76 | 13.60 | 14.73 | 834533.0 |
| Aug 10, 2026 | 13.82 | 14.19 | 13.43 | 13.74 | 944427.0 |
| Aug 07, 2026 | 12.90 | 14.00 | 12.80 | 13.92 | 1.370M |
| Aug 06, 2026 | 13.82 | 14.44 | 13.71 | 13.86 | 578255.0 |
| Aug 05, 2026 | 14.08 | 14.29 | 13.74 | 13.93 | 738926.0 |
| Aug 04, 2026 | 13.67 | 14.10 | 13.41 | 13.92 | 766895.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.58 |
| Alnylam Pharmaceuticals, Inc. | 260.10 |
| Anika Therapeutics, Inc. | 21.04 |
| Savara, Inc. | 5.53 |
| Vericel Corp. | 39.08 |
Price Related Metrics
| Price to Book Value | 5.200 |
| Earnings Yield | -4.43% |
| Market Cap | 1.172B |